COVID-19 vaccine development and a potential nanomaterial path forward

MD Shin, S Shukla, YH Chung, V Beiss… - Nature …, 2020 - nature.com
The COVID-19 pandemic has infected millions of people with no clear signs of abatement
owing to the high prevalence, long incubation period and lack of established treatments or …

Covid‐19 vaccines and variants of concern: a review

I Hadj Hassine - Reviews in medical virology, 2022 - Wiley Online Library
Since the outbreak of coronavirus disease 2019 (Covid‐19) in December 2019, caused by
the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the number of …

The SARS-CoV-2 main protease as drug target

S Ullrich, C Nitsche - Bioorganic & medicinal chemistry letters, 2020 - Elsevier
The unprecedented pandemic of the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) is threatening global health. The virus emerged in late 2019 and can cause a …

SARS-CoV-2 infection: The role of cytokines in COVID-19 disease

VJ Costela-Ruiz, R Illescas-Montes… - Cytokine & growth factor …, 2020 - Elsevier
COVID-19 disease, caused by infection with SARS-CoV-2, is related to a series of
physiopathological mechanisms that mobilize a wide variety of biomolecules, mainly …

[HTML][HTML] Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study

JR Lechien, CM Chiesa-Estomba, DR De Siati… - European Archives of …, 2020 - Springer
Objective To investigate the occurrence of olfactory and gustatory dysfunctions in patients
with laboratory-confirmed COVID-19 infection. Methods Patients with laboratory-confirmed …

Drug repurposing approach to fight COVID-19

TU Singh, S Parida, MC Lingaraju, M Kesavan… - Pharmacological …, 2020 - Springer
Currently, there are no treatment options available for the deadly contagious disease,
coronavirus disease 2019 (COVID-19). Drug repurposing is a process of identifying new …

[HTML][HTML] COVID-19, SARS and MERS: are they closely related?

N Petrosillo, G Viceconte, O Ergonul, G Ippolito… - Clinical microbiology …, 2020 - Elsevier
Background The 2019 novel coronavirus (SARS-CoV-2) is a new human coronavirus which
is spreading with epidemic features in China and other Asian countries; cases have also …

Understanding of COVID‐19 based on current evidence

P Sun, X Lu, C Xu, W Sun, B Pan - Journal of medical virology, 2020 - Wiley Online Library
Since December 2019, a series of unexplained pneumonia cases have been reported in
Wuhan, China. On 12 January 2020, the World Health Organization (WHO) temporarily …

The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China

Y Yang, F Peng, R Wang, K Guan, T Jiang, G Xu… - Journal of …, 2020 - Elsevier
The 2019-nCoV is officially called SARS-CoV-2 and the disease is named COVID-19. This
viral epidemic in China has led to the deaths of over 1800 people, mostly elderly or those …

Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis

Y Hu, J Sun, Z Dai, H Deng, X Li, Q Huang, Y Wu… - Journal of clinical …, 2020 - Elsevier
Background Since being first reported in Wuhan, China, in December 8, 2019, the outbreak
of the novel coronavirus, now known as COVID-19, has spread globally. Some case studies …